The expression profile of placental microRNAs as regulators of oxidative stress in fetal growth restriction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To evaluate the profile of differentially expressed microRNAs associated with oxidative stress and placental vascular dysfunction in fetal growth restriction (FGR). Materials and methods. Real-time quantitative RT-PCR was used to evaluate the placental tissue expression of microRNAs: miR-16-5p, miR-26b-5p, miR-100-5p, miR-125b-5p, miR-146a-5p, miR-182-5p, miR-199a-5p, miR-221-3p, miR-451a, and miR-574-3p in pregnant women with early- and late-onset FGR and control groups in the corresponding period. Results. Placental tissues from pregnant women with FGR were found to have signif icant changes in the expression levels of the microRNAs playing an important role in the regulation of oxidative stress: miR-125b-5p, miR-221-3p, miR-451a, and miR-574-3P in early-onset FGR and miR-451a and miR-574-3p in late-onset FGR. The DAVID database.v.6.8 could identify the potential targets of the above microRNAs that are determined as the key participants of a number of biological pathways: TGFβ-, TNFα-, VEGF-, HIF1α-, FOXO-, and MAPK-signaling pathways. Conclusion. The evaluation of the expression of the tissue-specific microRNAs regulating the balanced work of pro- and antioxidant system genes allows further determination of their diagnostic potential in the umbilical cord plasma and blood from pregnant women with FGR.

Full Text

Restricted Access

About the authors

Vladyslava A. Gusar

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: v_gusar@oparina4.ru
PhD, senior researcher of Laboratory of Applied Transriptomics, Department of System Biology in Reproduction

Angelika V. Timofeeva

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: v_timofeeva@oparina4.ru
PhD, senior researcher of Laboratory of Applied Transriptomics, Department of System Biology in Reproduction

Natalia E. Kan

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: n_kan@oparina4.ru
MD, professor, head of Department of Obstetric Observatory

Vitaliy V. Chagovets

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: v_chagovets@oparina4.ru
PhD, senior researcher of Laboratory of Proteomics and Metabolomics of Human Reproduction, Department of Systems Biology in Reproduction

Maria B. Ganichkina

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: m_ganichkina@oparina4.ru
graduate student

Vladimir E. Frankevich

National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russian Federation

Email: v_frankevich@oparina4.ru
PhD, head of Department of Systems Biology in Reproduction

References

  1. Devaskar S. U., Chu A. Intrauterine growth restriction: hungry for an answer. Physiology (Bethesda). 2016; 31(2): 131-46. https://dx.doi.org/10.1152/ physiol.00033.2015.
  2. Audette M.C., Kingdom J.C. Screening for fetal growth restriction and placental insufficiency. Semin. Fetal Neonatal Med. 2018; 23(2): 119-25. https://dx.doi. org/10.1016/j.siny.2017.11.004.
  3. Miller S.L., Huppi P.S., Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J. Physiol. 2016; 594(4): 807-23. https://dx.doi.org/.1113/JP271402.
  4. Schools M.H., Gordijn S.J., Scherjon S.A., van Goor H., Hillebrands J.L. Oxidative stress in placental pathology. Placenta. 2018; 69: 153-61. https:// dx.doi.org/10.1016/ j.placenta.2018.03.003.
  5. Myatt L., Cui X. Oxidative stress in the placenta. Histochem. Cell Biol. 2004; 122(4): 369-82. https://dx.doi.org/10.1007/s00418-004-0677-x.
  6. Higashijima A., Miura K., Mishima H., Kinoshita A., Jo O., Abe S. et al. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat. Diagn. 2013; 33(3): 214-22.
  7. Rudov A., Balduini W., Carloni S., Perrone S., Buonocore G., Cristina M. Involvement of miRNAs in placental alterations mediated by oxidative stress. Oxid. Med. Cell. Longev. 2014; 2014: 103068. https://dx.doi. org/10.1155/2014/103068.
  8. Magenta A., Greco S., Gaetano C., Martelli F. Oxidative stress and microRNA in vascular diseases. Int. J. Mol. Sci. 2013; 14(9): 17319-46.
  9. Cicchillitti L., Di Stefano V., Isaia E., Crimaldi L., Fasanaro P., Ambrosino V. et al. Hypoxia-inducible factor 1-alpha induces miR-210 in normoxic differentiating myoblasts. J. Biol. Chem. 2012; 287(53): 44761-71.
  10. Hu Y., Li P., Hao S., Liu L., Zhao J., Hou Y. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin. Chem. Lab. Med. 2009; 47(8): 923-9.
  11. Cross C.E., Tolba M.F., Rondelli C.M., Xu M., Abdel-Rahman S.Z. Oxidative stress alters miRNA and gene expression profiles in villous first trimester trophoblasts. Biomed. Res. Int. 2015; 2015: 257090. https://dx.doi.org/10.1155/2015/257090.
  12. Team R.C. R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria, 2017. Available at: https:// www.R-project.org/
  13. Hromadnikova I., Kotlabova K., Hympanova L., Krofta L. Cardiovascular and cerebrovascular disease associated microRNAs are dysregulated in placental tissues affected with gestational hypertension, preeclampsia and intrauterine growth restriction. PLoS One.| 2015; 10(9): e0138383. https://dx.doi. org/10.1371/journal.pone.0138383.
  14. Hromadnikova I., Kotlabova K., Ivankova K., Vedmetskaya Yu., Krofta L. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction. Int. J. Cardiol. 2017; 249: 402-9. https://dx.doi. org/10.1016/j.ijcard.2017.07.045.
  15. Hromadnikova I., Kotlabova K., Hympanova L., Krofta L. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb. Res. 2016; 137: 126-40.
  16. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J. Mol. Cell. Cardiol. 2012; 52(1): 245-55. https://dx.doi.org/ 10.1016/ j.yjmcc.2011.11.008.
  17. Sladek S.M., Magness R.R., Conrad K.P. Nitric oxide and pregnancy. Am. J. Physiol. 1997; 272(2, Pt 2): R441-63.
  18. Zhang C., Zhang J., Zhang A., Wang Y., Han L., You Y. et al. PUMA is a novel target of miR-221/222 in human epithelial cancers. Int. J. Oncol. 2010; 37(6): 1621-6.
  19. Liang Y., Xu J., Wang Y., Tang J.Y., Yang S.L., Xiang H.G. et al. Inhibition of MiRNA-125b decreases cerebral ischemia/reperfusion injury by targeting CK2a/NADPH oxidase signaling. Cell. Physiol. Biochem. 2018; 45(5): 1818-26. https://dx.doi.org/10.1159/000487873.
  20. Shen Y., Shen Z., Guo L., Zhang Q., Wang Z., Miao L. et al. MiR-125b-5p is involved in oxygen and glucose deprivation injury in PC-12 cells via CBS/ H2S pathway. Nitric Oxide. 2018; 78(1): 11-21. https://dx.doi.org/10.1016/j. niox.2018.05.004.
  21. Yu Q., Lu Z., Tao L., Yang L., Guo Y., Yang Y. et al. ROS-dependent neuroprotective effects of NaHS in ischemia brain injury involves the PARP/ AIF pathway. Cell. Physiol. Biochem. 2015; 36(4): 1539-51.
  22. Shah N.M., Zaitseva L., Bowles K.M., MacEwan D.J., Rushworth S.A. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival. Cell Death Differ. 2015; 22(4): 654-64. https://dx.doi.org/ 10.1038/cdd.2014.152.
  23. Mert I., Oruc A.S., Yukse S., Cakar E.S., Buyukkagnici U., Karaer A., Danisman N. Role of oxidative stress in preeclampsia and intrauterine growth restriction J. Obstet. Gynaecol. Res. 2012; 38(4): 658-64. https://dx.doi. org/10.1111/j.1447-0756.2011.01771.x.
  24. Biberoglu E., Biberoglu K., Kirbas A., Daglar K., Genc M., Avci A., Danisman N. Circulating and myometrial markers of oxidative stress in pregnant women with fetal growth restriction. J. Obstet. Gynaecol. Res. 2015; 42(1): 29-35. https:// dx.doi.org/10.1111/jog.12857.
  25. WangX., Zhu H., Zhang X., Liu Y., Chen J., Medvedovic M. et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc. Res. 2012; 94(2): 379-90.
  26. Yu D., dos Santos C.O., Zhao G., Jiang J., Amigo J.D., Khandros E. et al. MiR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 2010; 24(15): 1620-33.
  27. Alural B., Duran G.A., Tufekci K.U., Allmer J., Onkal Z., Tunali D. et al. EPO mediates neurotrophic, neuroprotective, anti-oxidant, and anti-apoptotic effects via downregulation of miR-451 and miR-885-5p in SH-SY5Y neuron-like cells. Front. Immunol. 2014; 4: 475. https://dx.doi.org/10.3389/fimmu.2014.00475.
  28. Bostjancic E., Zidar N., Glavac D. MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatics analysis. BMC Genomics. 2012; 13(1): 552.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies